Integer to Showcase Leadership in Medical Device Innovation and Recent Acquisition of Precision Coating at MD&M West 2025
Integer Holdings (NYSE: ITGR) will exhibit at MD&M West 2025 from February 4-6 at the Anaheim Convention Center, showcasing their medical device manufacturing capabilities at booth #1439. The company will demonstrate their expertise in cardio and vascular solutions, cardiac rhythm management, and neuromodulation products, including their global rapid prototyping services with two-week turnarounds.
A significant highlight is Integer's recent acquisition of Precision Coating for $152 million on January 7, 2025. This strategic move enhances Integer's capabilities with specialized surface coating technologies, including fluoropolymer, anodic coatings, ion treatment solutions, and laser processing. The acquisition aligns with Integer's tuck-in strategy and expands their service offerings to better serve customer needs.
The company will provide more details about the Precision Coating acquisition during their Q4 and full-year 2024 earnings call scheduled for February 20, 2025.
Integer Holdings (NYSE: ITGR) esporrà al MD&M West 2025 dal 4 al 6 febbraio presso il Centro Congressi di Anaheim, presentando le proprie capacità di produzione di dispositivi medici presso lo stand n. 1439. L'azienda dimostrerà la propria esperienza in soluzioni cardio e vascolari, gestione del ritmo cardiaco e prodotti di neuromodulazione, inclusi i servizi globali di prototipazione rapida con tempi di consegna di due settimane.
Un elemento di spicco è la recente acquisizione di Precision Coating per 152 milioni di dollari avvenuta il 7 gennaio 2025. Questa mossa strategica migliora le capacità di Integer con tecnologie di rivestimento superficiale specializzate, inclusi fluoropolimeri, rivestimenti anodici, soluzioni di trattamento ionico e lavorazione laser. L'acquisizione si allinea con la strategia tuck-in di Integer e amplifica le loro offerte di servizi per meglio soddisfare le esigenze dei clienti.
L'azienda fornirà ulteriori dettagli sull'acquisizione di Precision Coating durante la loro chiamata sugli utili del quarto trimestre e dell'intero anno 2024, programmata per il 20 febbraio 2025.
Integer Holdings (NYSE: ITGR) exhibirá en MD&M West 2025 del 4 al 6 de febrero en el Centro de Convenciones de Anaheim, mostrando sus capacidades de fabricación de dispositivos médicos en el stand n. 1439. La compañía demostrará su experiencia en soluciones cardiacas y vasculares, gestión del ritmo cardíaco y productos de neuromodulación, incluidos sus servicios globales de prototipado rápido con tiempos de entrega de dos semanas.
Un punto destacado es la reciente adquisición de Precision Coating por 152 millones de dólares el 7 de enero de 2025. Este movimiento estratégico mejora las capacidades de Integer con tecnologías de recubrimiento superficial especializadas, incluidos fluoropolímeros, recubrimientos anódicos, soluciones de tratamiento iónico y procesamiento láser. La adquisición se alinea con la estrategia tuck-in de Integer y amplía su oferta de servicios para atender mejor las necesidades de los clientes.
La compañía proporcionará más detalles sobre la adquisición de Precision Coating durante su llamada de ganancias del cuarto trimestre y del año completo 2024, programada para el 20 de febrero de 2025.
Integer Holdings (NYSE: ITGR)는 2025년 2월 4일부터 6일까지 애너하임 컨벤션 센터에서 열리는 MD&M West 2025에 참가하여 부스 #1439에서 의료기기 제조 능력을 선보입니다. 이 회사는 심혈관 솔루션, 심장 리듬 관리 및 신경 조절 제품에서의 전문성을 보여주며, 2주 만에 완료되는 글로벌 신속 프로토타입 서비스도 포함됩니다.
주요 하이라이트는 2025년 1월 7일에 이루어진 Precision Coating의 1억 5200만 달러 인수입니다. 이 전략적 결정은 플루오로폴리머, 양극 코팅, 이온 처리 솔루션 및 레이저 가공을 포함한 특수 표면 코팅 기술을 통해 Integer의 능력을 강화합니다. 이 인수는 Integer의 턱인 전략과 일치하며 고객의 요구를 더 잘 충족시키기 위한 서비스 제공 범위를 확장합니다.
회사는 2025년 2월 20일 예정인 2024년 4분기 및 연례 실적 발표 전화 회의에서 Precision Coating 인수에 대한 추가 정보를 제공할 예정입니다.
Integer Holdings (NYSE: ITGR) sera présent au MD&M West 2025 du 4 au 6 février au Anaheim Convention Center, où il mettra en avant ses capacités de fabrication de dispositifs médicaux au stand n°1439. L'entreprise démontrera son expertise en solutions cardio-vasculaires, en gestion du rythme cardiaque et en produits de neuromodulation, y compris ses services mondiaux de prototypage rapide avec des délais de livraison de deux semaines.
Un point marquant est la récente acquisition de Precision Coating pour 152 millions de dollars, réalisée le 7 janvier 2025. Ce mouvement stratégique renforce les capacités d’Integer avec des technologies de revêtement de surface spécialisées, notamment des fluoropolymères, des revêtements anodiques, des solutions de traitement par ions et du traitement laser. L’acquisition s'inscrit dans la stratégie de consolidation d’Integer et élargit son offre de services pour mieux répondre aux besoins des clients.
L'entreprise fournira plus de détails sur l'acquisition de Precision Coating lors de sa conférence téléphonique sur les résultats du quatrième trimestre et de l'année complète 2024, prévue pour le 20 février 2025.
Integer Holdings (NYSE: ITGR) wird vom 4. bis 6. Februar 2025 auf der MD&M West im Anaheim Convention Center ausstellen und seine Fähigkeiten in der Herstellung von Medizinprodukten am Stand Nr. 1439 präsentieren. Das Unternehmen wird seine Expertise in kardiovaskulären Lösungen, kardialem Rhythmusmanagement und Neuromodulationsprodukten demonstrieren, einschließlich seiner globalen Rapid-Prototyping-Dienste mit zweiwöchigen Lieferzeiten.
Ein bedeutendes Highlight ist die Übernahme von Precision Coating für 152 Millionen Dollar am 7. Januar 2025. Dieser strategische Schritt verbessert die Fähigkeiten von Integer durch spezialisierte Oberflächenbeschichtungstechnologien, einschließlich Fluorpolymer, anodischer Beschichtungen, Ionenbehandlungslösungen und Laserbearbeitung. Die Übernahme entspricht der Tuck-in-Strategie von Integer und erweitert das Dienstleistungsangebot, um die Bedürfnisse der Kunden besser zu erfüllen.
Das Unternehmen wird weitere Einzelheiten zur Übernahme von Precision Coating während der Telefonkonferenz zu den Ergebnissen für das vierte Quartal und das Gesamtjahr 2024, die für den 20. Februar 2025 geplant ist, bereitstellen.
- Acquired Precision Coating for $152M, expanding coating technology capabilities
- Strategic expansion of service offerings through tuck-in acquisition
- Implementation of rapid prototyping services with 2-week turnaround time
- None.
~ Attendees Invited to Visit Integer at Booth #1439 ~
PLANO, Texas, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), will join innovators and industry leaders around the world in exhibiting at MD&M West, Feb. 4 – 6, 2025, at the Anaheim Convention Center in Anaheim, California.
Integer welcomes visitors to booth #1439 to learn more about the company’s commitment to customers as their partner of choice in enhancing the lives of patients through access to innovative technologies, superior quality and dependable manufacturing to accelerate speed to market and reduce product development risk.
Integer’s exhibit will showcase capabilities and solutions to enable cardio and vascular, cardiac rhythm management and neuromodulation products, and how the company blends technology, expertise and resources to amplify customers’ innovation.
Integer will additionally highlight its global rapid prototyping services that enable customers’ direct access to a team of dedicated experts in R&D and engineering. With a local-to-local approach and as little as a two-week turnaround, customers now can obtain rapid prototypes in specialized cardiovascular markets, including structural heart, electrophysiology and neurovascular. Offerings include catheter shafts and guidewires, steerable sheaths, introducers, braiding and textiles, and machined components.
“As we expand our capabilities and capacity through ongoing strategic investments, we will continue to anticipate our customers’ needs in a highly innovative and rapidly evolving medical device landscape,” said Payman Khales, President, Cardio and Vascular. “We look forward to demonstrating our collaborative approach, continued commitment to innovation, and the strategic value we provide as our customers’ trusted and reliable end-to-end partner in medical device technologies.”
Integer will also showcase a range of key product areas throughout the event, including:
- Cardiac rhythm management and neuromodulation: Miniaturized technology for finished IPGs as well as Gen 3 Li Ion and Gen 2 CFx batteries.
- Cardio and vascular solutions: A full range of electrophysiology, structural heart, and neurovascular product solutions including complex catheters, high-performing guidewires, steerable introducers and sheaths, therapy delivery systems, and implant technologies.
In addition to Integer’s exhibit at booth #1439, MD&M West 2025 attendees can visit Pulse Technologies, an Integer Company, at booth #2854 to learn more about HSR technology and complex micro machining for critical medical device components.
Attendees are also invited to visit Precision Coating at booth #2269. Integer acquired substantially all of the assets of Precision Coating, a privately held manufacturer specializing in high value surface coating technology platforms, including fluoropolymer, anodic coatings, ion treatment solutions and laser processing, on Jan. 7, 2025, for
Integer will share additional details on this acquisition during its fourth quarter and full year 2024 earnings call on Feb. 20, 2025.
Learn more about Integer at www.integer.net.
About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net.
| Investor Relations: | Media Relations: |
| Andrew Senn | Kelly Butler |
| andrew.senn@integer.net | kelly.butler@integer.net |
| 763.951.8312 | 469.731.6617 |
FAQ
How much did Integer Holdings (ITGR) pay for Precision Coating acquisition?
What technologies did ITGR gain through the Precision Coating acquisition?
When will Integer Holdings (ITGR) discuss the Precision Coating acquisition details?
What is the turnaround time for Integer's (ITGR) rapid prototyping services?
